Cardiogenic shock with non-ST-segment elevation myocardial infarction: A report from the SHOCK Trial Registry

Journal of the American College of Cardiology

Volumn 36, Issue 3 SUPPL. A, 2000, Pages 1091-1096

  Jacobs, Alice K ^a   French, John K ^b   Col, Jacques ^c   Sleeper, Lynn A ^d   Slater, James N ^e   Carnendran, Louis ^e   Boland, Jean ^f   Jiang, Xianjiao ^d   LeJemtel, Thierry ^g   Hochman, Judith S ^e  

^a BOSTON MEDICAL CENTER   (United States)

^b GREEN LANE HOSPITAL   (New Zealand)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^d NEW ENGLAND RESEARCH INSTITUTES   (United States)

^e ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^f Centre Hospitalier Regional de La Citadelle   (Belgium)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART EJECTION FRACTION; HEART HEMODYNAMICS; HEART MUSCLE REVASCULARIZATION; HUMAN; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; ST SEGMENT ELEVATION; SURVIVAL RATE; TREATMENT OUTCOME; UREMIA;

AGED; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HOSPITAL MORTALITY; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROSPECTIVE STUDIES; REGISTRIES; SHOCK, CARDIOGENIC; THROMBOLYTIC THERAPY;

EID: 0033865359     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00888-3     Document Type: Article

References (33)

1. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
2. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
3. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
4. Favorable long-term prognosis of acute non-Q-wave myocardial infarction associated with absent or nonspecific electrocardiographic changes
5. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction
6. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction
7. Comparison of primary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review
8. Contemporary management of non-Q-wave myocardial infarction
9. Effect of early revascularization on mortality in cardiogenic shock complicating acute myocardial infarction
10. Current spectrum of cardiogenic shock and effect of early revascularization on mortality
11. Cardiogenic shock complicating acute myocardial infarction -Etiologies, management and outcome: A report from the SHOCK Trial Registry
12. Cardiogenic shock after acute myocardial infarction; incidence and mortality from a community-wide perspective, 1975 to 1988
13. Multicenter registry of angioplasty therapy of cardiogenic shock: Initial and long-term survival
14. Temporal trends in cardiogenic shock complicating acute myocardial infarction
15. Risk stratification of patients with non-Q-wave myocardial infarction: The critical role of ST segment depression
16. Acute myocardial infarction: Does the lack of Q waves help or hinder?
17. Anatomic non specificity of Q-wave and ST infarcts
18. Transmural vs. non-transmural infarction
19. The Q-wave and non-Q-wave myocardial infarction: Differences and similarities
20. Nontransmural myocardial infarction: A comparison of hospital and late clinical course of patients with that of matched patients with transmural anterior and transmural inferior myocardial infarction
21. Clinical, functional, and angiographic distinctions between Q wave and non-Q-wave myocardial infarction: Evidence of spontaneous reperfusion and implications for intervention trials
22. Comparison of coronary angiographic findings during the first six hours of non-Q-wave and Q-wave myocardial infarction
23. Coronary arteriographic findings soon after non-Q-wave myocardial infarction
24. Factors presaging early recurrent myocardial infarction ('extension')
25. Recurrent myocardial infarction: Clinical predictors and prognostic implications
26. The unstable ST segment early after thrombolysis for acute infarction and its usefulness as a marker of recurrent coronary occlusion
27. Non-Q-wave myocardial infarction revisited: 10 years later
28. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation
29. Electrocardiographic evolution of posterior acute myocardial infarction: Importance of early precordial ST-segment depression
30. Percutaneous transluminal coronary angioplasty in patients with cardiogenic shock
31. Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction
32. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era
33. One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization: Results from the GUSTO-I trial